Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Risto Vesalainen"'
Autor:
Salme Järvenpää, Pertti Aarnio, Hannu Kautiainen, Päivi Korhonen, Ilkka Kantola, Risto Vesalainen
Publikováno v:
Scandinavian Journal of Primary Health Care. 30:101-106
Objective. This study aimed at investigating whether cardiovascular risk factors and their impact on total risk estimation differ between men and women. Design. Cross-sectional cohort study. Subjects. Finnish cardiovascular risk subjects (n = 904) wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fed63f4a2583afb7241c1b67e9466a3
https://doi.org/10.3109/02813432.2012.675564
https://doi.org/10.3109/02813432.2012.675564
Autor:
Minna Sillanpää, Veli-Matti T. Leinonen, Juha Varis, Risto Vesalainen, Johanna Päivärinta, Ilkka Kantola
Publikováno v:
European Journal of Cardiovascular Prevention & Rehabilitation. 18:136-140
BACKGROUND Nonsteroidal anti-inflammatory drugs (NSAIDs) may increase blood pressure (BP) and potentially reduce the efficacy of several antihypertensive drugs. We evaluated the effect of low-dose acetylsalicylic acid (ASA) on BP control in drug-trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84c9b9687522f9e6c992223584db7fb
https://doi.org/10.1097/hjr.0b013e32833ace3a
https://doi.org/10.1097/hjr.0b013e32833ace3a
Autor:
Ilkka Kantola, Risto Vesalainen, Salme Järvenpää, Pertti Aarnio, Päivi Korhonen, Hannu Kautiainen, Tarja Saaresranta
Publikováno v:
Annals of Medicine. 42:187-195
Recently published guidelines emphasize that detection of any subclinical target organ damage in hypertensive subjects should be regarded as a sign of high cardiovascular risk.To assess the ability of conventional multivariable cardiovascular disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88cab3e08923dc9e9b06714cd3dde434
https://doi.org/10.3109/07853890903521088
https://doi.org/10.3109/07853890903521088
Autor:
Ilkka Kantola, Salme Järvenpää, Pertti Aarnio, Kari T. Syvänen, Risto Vesalainen, Hannu Kautiainen, Päivi Korhonen
Publikováno v:
Journal of Hypertension. 27:2036-2043
BACKGROUND Hypertension is an established risk factor for peripheral arterial disease (PAD), but the prevalence of this condition in hypertensive patients without comorbidities is unknown. METHODS In this study, we assess the prevalence and factors a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d807812010fb826f429878071195b7d1
https://doi.org/10.1097/hjh.0b013e32832f4f54
https://doi.org/10.1097/hjh.0b013e32832f4f54
Autor:
Ilkka Kantola, Hannu Kautiainen, Tarja Saaresranta, S Järvenpää, Risto Vesalainen, Päivi Korhonen, P Aarnio
Publikováno v:
Journal of Human Hypertension. 23:97-104
The prevalence of renal insufficiency in hypertensive participants without comorbidities affecting renal function is unknown. The objective of this study was to assess the prevalence and predictors of renal insufficiency in general hypertensive popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4046388fd02be837b39a2d3374b6e729
https://doi.org/10.1038/jhh.2008.115
https://doi.org/10.1038/jhh.2008.115
Autor:
Tuula Janatuinen, Terho Lehtimäki, Pekka J. Karhunen, Juhani Knuuti, Erkki Ilveskoski, Reijo Laaksonen, Risto Vesalainen, Pekka Laippala, Pirjo Nuutila
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 67:723-734
Apolipoprotein E (apoE) polymorphism affects the risk of advanced coronary artery disease, but its role in early atherosclerosis remains unknown. We used positron emission tomography (PET) to study whether coronary reactivity or its response to prava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f216b55b0f755ef50130ab0285eba33b
https://doi.org/10.1080/00365510701297472
https://doi.org/10.1080/00365510701297472
Autor:
Terho Lehtimäki, Reijo Laaksonen, Tuula Janatuinen, Juhani Knuuti, Pirjo Nuutila, Riikka Rontu, Hanna Laine, Yue-Mei Fan, Olli T. Raitakari, Risto Vesalainen
Publikováno v:
Atherosclerosis. 188:391-397
Background The hepatic lipase (HL) gene C-480T promoter polymorphism affects gene transcription and enzyme activity and leads to CC, CT, and TT genotypes. Recently, HL expression was detected in macrophages. It has been postulated that HL might have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91396e06690cc700565b6656499cbe62
https://doi.org/10.1016/j.atherosclerosis.2005.11.003
https://doi.org/10.1016/j.atherosclerosis.2005.11.003
Publikováno v:
American Journal of Hypertension. 19:468-474
The purpose of this study was to compare home and ambulatory blood pressure (BP) in the adjustment of antihypertensive treatment.After a 4-week washout period, patients whose untreated daytime diastolic ambulatory BP averagedor = 85 mm Hg were random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::243ce6c4d47f8796778b3b260fb70b1a
https://doi.org/10.1016/j.amjhyper.2005.10.017
https://doi.org/10.1016/j.amjhyper.2005.10.017
Autor:
Hannu Päivä, Riikka Rontu, Tuula Janatuinen, Reijo Laaksonen, Terho Lehtimäki, Juhani Knuuti, Jussi Matinheikki, Dieter Lütjohann, Karin M. Thelen, Klaus von Bergmann, Risto Vesalainen
Publikováno v:
Atherosclerosis. 185:206-209
Sterol regulatory element binding proteins-1 and -2 (SREBPs) are transcription factors controlling lipid homeostasis in human cells. The G-allele carriers of the SREBF-1 gene C-G polymorphism in exon 18c and coding for glycine at the protein level (G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8322215b769e62697b3eb996ffd2421a
https://doi.org/10.1016/j.atherosclerosis.2005.06.007
https://doi.org/10.1016/j.atherosclerosis.2005.06.007
Autor:
Juhani Knuuti, Tuula Janatuinen, Reijo Laaksonen, Klaus von Bergmann, Risto Vesalainen, Karin M. Thelen, Dieter Lütjohann, Terho Lehtimäki
Publikováno v:
European Journal of Clinical Pharmacology. 62:9-14
The HMG-CoA reductase inhibitors, or statins, are well established in the prevention and treatment of coronary artery disease, mainly by lowering low-density lipoprotein (LDL) cholesterol levels. These compounds are structurally similar, but differ i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75a1cc7a1d77a1f8c7d8480d3ae43ad7
https://doi.org/10.1007/s00228-005-0068-9
https://doi.org/10.1007/s00228-005-0068-9